<SEC-DOCUMENT>0001213900-26-002949-index.html : 20260109
<SEC-HEADER>0001213900-26-002949.hdr.sgml : 20260109
<ACCEPTANCE-DATETIME>20260109163024
ACCESSION NUMBER:		0001213900-26-002949
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260107
FILED AS OF DATE:		20260109
DATE AS OF CHANGE:		20260109

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Rolfe Lindsey
		CENTRAL INDEX KEY:			0001650504
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40877
		FILM NUMBER:		26523405

	MAIL ADDRESS:	
		STREET 1:		C/O CLOVIS ONCOLOGY, INC.
		STREET 2:		499 ILLINOIS STREET, SUITE 200
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CERO THERAPEUTICS HOLDINGS, INC.
		CENTRAL INDEX KEY:			0001870404
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				871088814
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		201 HASKINS WAY
		STREET 2:		SUITE 230
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-407-2376

	MAIL ADDRESS:	
		STREET 1:		201 HASKINS WAY
		STREET 2:		SUITE 230
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHOENIX BIOTECH ACQUISITION CORP.
		DATE OF NAME CHANGE:	20210630
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>